Medicare Enrolled

Dr. Guillermo De Angulo, MD

Pediatric Hematology & Oncology Physician · Miami, FL
3100 SW 62ND AVENUE, Miami, FL 33155
3056628360
Registered in NPPES since 2007
NPI: 1679791370 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. De Angulo from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. De Angulo? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. De Angulo

Dr. Guillermo De Angulo is a pediatric hematology & oncology physician in Miami, FL, with 19 years of NPI registration.

Between the years covered by Open Payments, Dr. De Angulo received a total of $748,722 from 29 pharmaceutical and/or device companies across 531 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. De Angulo is High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years of NPI registration $748,722 industry payments

Florida License Status

FL DOH · MQA
1
Active license
None
Board action on record
0
Recent admin complaints
Profession License # Status Expires Board Action
Medical Doctor 98389 Clear January 31, 2027 —
Data from Florida Department of Health Medical Quality Assurance. License records are public under Chapter 119, Florida Statutes. Verify directly on FL DOH →

Industry Payment Transparency

Open Payments through 2024 ↗
$748,722
Total received (2018-2024)
Avg $106,960/year across 7 years
Top 0% in FL for pediatric hematology & oncology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
29
Companies
531
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$125,310
2023
$241,237
2022
$86,934
2021
$54,820
2020
$49,437
2019
$111,918
2018
$79,066

Payments by company (2024)

JAZZ PHARMACEUTICALS INC.
$42,866
GENZYME CORPORATION
$37,940
United Therapeutics Corporation
$29,827
Amgen Inc.
$12,586
SERVIER PHARMACEUTICALS LLC
$1,731
bluebird bio, Inc.
$52
PFIZER INC.
$38
Novartis Pharmaceuticals Corporation
$34
Astellas Pharma US Inc
$29
Bayer Healthcare Pharmaceuticals Inc.
$24
Alexion Pharmaceuticals, Inc.
$24
Novo Nordisk Inc
$23
SOBI, INC
$23
USWM, LLC
$22
RARE DISEASE THERAPEUTICS, INC.
$22
Emmaus Medical, Inc.
$19
HEMA Biologics, LLC
$18
Agios Pharmaceuticals, Inc.
$17
BTG International, Inc.
$16
Top 3 companies account for 88.3% of 2024 payments
All-time payments by company (2018-2024) ›
GENZYME CORPORATION
$195,990
United Therapeutics Corporation
$140,351
Amgen Inc.
$110,809
BIOVERATIV THERAPEUTICS INC.
$95,760
JAZZ PHARMACEUTICALS INC.
$88,631
Jazz Pharmaceuticals Inc.
$37,959
SERVIER PHARMACEUTICALS LLC
$35,496
SANOFI-AVENTIS U.S. LLC
$26,019
Octapharma USA, Inc.
$12,695
Servier Pharmaceuticals LLC
$2,380
Alkermes, Inc.
$1,900
Novartis Pharmaceuticals Corporation
$108
Novo Nordisk Inc
$71
Genentech USA, Inc.
$70
PFIZER INC.
$67
Alexion Pharmaceuticals, Inc.
$64
bluebird bio, Inc.
$52
Bayer HealthCare Pharmaceuticals Inc.
$44
Bayer Healthcare Pharmaceuticals Inc.
$39
Emmaus Medical, Inc.
$32
Astellas Pharma US Inc
$29
Takeda Pharmaceuticals U.S.A., Inc.
$24
SOBI, INC
$23
USWM, LLC
$22
RARE DISEASE THERAPEUTICS, INC.
$22
HEMA Biologics, LLC
$18
Agios Pharmaceuticals, Inc.
$17
BTG International, Inc.
$16
BioMarin Pharmaceutical Inc.
$15
Top 3 companies account for 59.7% of all-time payments
Associated products mentioned in payments ›
ALPROLIX · ALTUVIIIO · ASPARLAS · Asparlas · Blincyto · CABLIVI · Cresemba · ELITEK · ELOCTATE · Endari · Erwinaze · Esperoct · FIBRYGA · GAMIFANT · HEMLIBRA · Hemlibra · IWILFIN · Jivi · KOSELUGO · MEKINIST · NO PRODUCT DISCUSSED · NUWIQ · NovoSeven · Novoeight · ONCASPAR · PROMACTA · PYRUKYND · Purixan · RYLAZE · Roctavian · SOLIRIS · SevenFact · Tibsovo · UNITUXIN · VPRIV · Vitrakvi · Voraxaze · WILATE · WILATE - VON WILLEBRAND FACTOR/COAGULATION FACTOR VIII COMPLEX (HUMAN) · XYNTHA · Zynteglo
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a pediatric hematology & oncology physician in Miami?
Compare pediatric hematology & oncology physicians in the Miami area by procedure volume, costs, and industry payment transparency.
Browse pediatric hematology & oncology physicians nearby

Geographic Context

Pediatric hematology & oncology physicians in nearby ZIP areas
28
County median income
$68,694
Nearest hospital to ZIP centroid (approximate)
KERALTY HOSPITAL
0.0 mi

Data Sources

Provider Registry ✓ NPPES NPPES snapshot; verify current record
Medicare Enrollment ✓ PECOS PECOS snapshot
Practice Data — No data N/A
Industry Payments ✓ Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. De Angulo is a pediatric hematology & oncology physician, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Does Dr. De Angulo receive payments from pharmaceutical companies?
Yes. Dr. De Angulo received a total of $748,722 from 29 companies across 531 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently High for Dr. De Angulo) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →

Explore related providers

Same specialty & city
Pediatric Hematology & Oncology Physicians in Miami
Browse pediatric hematology & oncology physicians in Miami ranked by procedure volume and transparency data.
Highest volume
Top Pediatric Hematology & Oncology Physicians in FL
Pediatric hematology & oncology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pediatric Hematology & Oncology Physicians in FL
Which FL pediatric hematology & oncology physicians receive the most from drug and device companies.
By company
GENZYME CORPORATION Payments to Doctors
See all physicians who received payments from GENZYME CORPORATION.
By company
United Therapeutics Corporation Payments to Doctors
See all physicians who received payments from United Therapeutics Corporation.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →